Analysis of eIF4E and 4EBP1 mRNAs in head and neck cancer

Objectives/Hypothesis: The eukaryotic translation initiation factor 4E (eIF4E) in conjunction with its binding protein, 4EBP1, regulates the translation of cap‐dependent mRNAs. An aberrant increase in eIF4E shifts the balance in favor of translation of transcripts that promote cell proliferation and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Laryngoscope 2011-10, Vol.121 (10), p.2136-2141
Hauptverfasser: Sunavala-Dossabhoy, Gulshan, Palaniyandi, Senthilnathan, Clark, Cheryl, Nathan, Cherie-Ann O., Abreo, Fleurette W., Caldito, Gloria
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2141
container_issue 10
container_start_page 2136
container_title The Laryngoscope
container_volume 121
creator Sunavala-Dossabhoy, Gulshan
Palaniyandi, Senthilnathan
Clark, Cheryl
Nathan, Cherie-Ann O.
Abreo, Fleurette W.
Caldito, Gloria
description Objectives/Hypothesis: The eukaryotic translation initiation factor 4E (eIF4E) in conjunction with its binding protein, 4EBP1, regulates the translation of cap‐dependent mRNAs. An aberrant increase in eIF4E shifts the balance in favor of translation of transcripts that promote cell proliferation and malignancy. eIF4E protein is commonly elevated in head and neck squamous cell carcinomas (HNSCC), and its overexpression is associated with increased recurrence. An underlying mechanism for eIF4E overexpression is gene amplification, and we wanted to determine whether eIF4E mRNA could serve as a prognostic maker of HNSCC. Methods: Tumor specimens from 26 HNSCC patients and oral tissues from 17 control subjects were examined for eIF4E and 4EBP1 by semiquantitative RT‐PCR and correlated with clinical and pathologic findings. Results: Unlike eIF4E mRNA alone, expression of eIF4E relative to 4EBP1 was a more precise predictor of HNSCC and its progression (P < .01, Wilcoxon rank sum test). Eight of 26 patients (31%) had elevated eIF4E:4EBP1 (4E:4EBP1; >25), and 7 of these (87.5%) had recurrence. Alternately, from 18 patients with low 4E:4EBP1 (
doi_str_mv 10.1002/lary.22144
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_894817155</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>894817155</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3964-959b6254beb9b9d12bfc4b66e640e1103128babab59aae915e0254f2b19c730a3</originalsourceid><addsrcrecordid>eNp9kE1Lw0AQhhdRtFYv_gDJRQQhdWc_kuyxllYrRUtR1NOyu5lgNElr1qL996Yf1pvsYWDnmXeYh5AToB2glF0Wpl50GAMhdkgLJIdQKCV3Satp8jCR7PmAHHr_RinEXNJ9csAgUYngvEVUtzLFwuc-mGYBDgeiH5gqDUT_agxBObnr-iCvglc06eq_QvceOFM5rI_IXmYKj8eb2iaPg_5D7yYc3V8Pe91R6LiKRKikshGTwqJVVqXAbOaEjSKMBEUAyoEl1jRPKmNQgUTa0BmzoFzMqeFtcr7OndXTjzn6T13m3mFRmAqnc68TJRKIQcqGvFiTrp56X2OmZ3VeNnI0UL00pZem9MpUA59uYue2xHSL_qppgLMNYLwzRVY3V-f-jxMRjSFZBsGa-8oLXPyzUo-6k5ff5eF6Jvef-L2dMfW7jmIeS_10d60nqjd4GN_2tOQ_5lOMBg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>894817155</pqid></control><display><type>article</type><title>Analysis of eIF4E and 4EBP1 mRNAs in head and neck cancer</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Sunavala-Dossabhoy, Gulshan ; Palaniyandi, Senthilnathan ; Clark, Cheryl ; Nathan, Cherie-Ann O. ; Abreo, Fleurette W. ; Caldito, Gloria</creator><creatorcontrib>Sunavala-Dossabhoy, Gulshan ; Palaniyandi, Senthilnathan ; Clark, Cheryl ; Nathan, Cherie-Ann O. ; Abreo, Fleurette W. ; Caldito, Gloria</creatorcontrib><description>Objectives/Hypothesis: The eukaryotic translation initiation factor 4E (eIF4E) in conjunction with its binding protein, 4EBP1, regulates the translation of cap‐dependent mRNAs. An aberrant increase in eIF4E shifts the balance in favor of translation of transcripts that promote cell proliferation and malignancy. eIF4E protein is commonly elevated in head and neck squamous cell carcinomas (HNSCC), and its overexpression is associated with increased recurrence. An underlying mechanism for eIF4E overexpression is gene amplification, and we wanted to determine whether eIF4E mRNA could serve as a prognostic maker of HNSCC. Methods: Tumor specimens from 26 HNSCC patients and oral tissues from 17 control subjects were examined for eIF4E and 4EBP1 by semiquantitative RT‐PCR and correlated with clinical and pathologic findings. Results: Unlike eIF4E mRNA alone, expression of eIF4E relative to 4EBP1 was a more precise predictor of HNSCC and its progression (P &lt; .01, Wilcoxon rank sum test). Eight of 26 patients (31%) had elevated eIF4E:4EBP1 (4E:4EBP1; &gt;25), and 7 of these (87.5%) had recurrence. Alternately, from 18 patients with low 4E:4EBP1 (&lt;25; 69%), only 5 patients had recurrence (30.1%). To determine the probability of no recurrence, Kaplan–Meier analysis showed significantly poor disease‐free survival in patients with elevated 4E:4EBP1 than those with low ratios (P &lt; .01, log rank test). Conclusions: Elevated 4E:4EBP1 significantly correlated with increased disease recurrence. Because 4EBP1 modulates eIF4E activity, our results highlight the importance of incorporating a joint analysis of eIF4E and 4EBP1 mRNAs in HNSCC patient care decisions.</description><identifier>ISSN: 0023-852X</identifier><identifier>EISSN: 1531-4995</identifier><identifier>DOI: 10.1002/lary.22144</identifier><identifier>PMID: 21898433</identifier><identifier>CODEN: LARYA8</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>4EBP1 ; Adaptor Proteins, Signal Transducing - genetics ; Adaptor Proteins, Signal Transducing - metabolism ; Adult ; Aged ; Biological and medical sciences ; biomarker ; Biomarkers, Tumor - metabolism ; Biopsy, Needle ; Carcinoma - genetics ; Carcinoma - mortality ; Carcinoma - pathology ; Carcinoma, Squamous Cell ; Chi-Square Distribution ; Cohort Studies ; Disease Progression ; eIF4E ; Eukaryotic Initiation Factor-4E - genetics ; Eukaryotic Initiation Factor-4E - metabolism ; Female ; head and neck cancer ; Head and Neck Neoplasms - genetics ; Head and Neck Neoplasms - mortality ; Head and Neck Neoplasms - pathology ; Humans ; Level 2b ; Level of Evidence: Prognosis Study ; Level of Evidence: Prognosis Study, Level 2b ; Male ; Medical sciences ; Middle Aged ; Neoplasm Invasiveness - pathology ; Neoplasm Recurrence, Local - genetics ; Neoplasm Recurrence, Local - metabolism ; Neoplasm Staging ; Neoplasms, Squamous Cell - genetics ; Neoplasms, Squamous Cell - mortality ; Neoplasms, Squamous Cell - pathology ; Otorhinolaryngology (head neck, general aspects and miscellaneous) ; Otorhinolaryngology. Stomatology ; Predictive Value of Tests ; Prognosis ; Reverse Transcriptase Polymerase Chain Reaction ; Risk Assessment ; RNA, Messenger - analysis ; RNA-Binding Proteins - genetics ; RNA-Binding Proteins - metabolism ; Sensitivity and Specificity ; Squamous Cell Carcinoma of Head and Neck ; Statistics, Nonparametric ; Survival Analysis ; Tissue Culture Techniques ; Tumors</subject><ispartof>The Laryngoscope, 2011-10, Vol.121 (10), p.2136-2141</ispartof><rights>Copyright © 2011 The American Laryngological, Rhinological, and Otological Society, Inc.</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3964-959b6254beb9b9d12bfc4b66e640e1103128babab59aae915e0254f2b19c730a3</citedby><cites>FETCH-LOGICAL-c3964-959b6254beb9b9d12bfc4b66e640e1103128babab59aae915e0254f2b19c730a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Flary.22144$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Flary.22144$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=24607184$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21898433$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sunavala-Dossabhoy, Gulshan</creatorcontrib><creatorcontrib>Palaniyandi, Senthilnathan</creatorcontrib><creatorcontrib>Clark, Cheryl</creatorcontrib><creatorcontrib>Nathan, Cherie-Ann O.</creatorcontrib><creatorcontrib>Abreo, Fleurette W.</creatorcontrib><creatorcontrib>Caldito, Gloria</creatorcontrib><title>Analysis of eIF4E and 4EBP1 mRNAs in head and neck cancer</title><title>The Laryngoscope</title><addtitle>The Laryngoscope</addtitle><description>Objectives/Hypothesis: The eukaryotic translation initiation factor 4E (eIF4E) in conjunction with its binding protein, 4EBP1, regulates the translation of cap‐dependent mRNAs. An aberrant increase in eIF4E shifts the balance in favor of translation of transcripts that promote cell proliferation and malignancy. eIF4E protein is commonly elevated in head and neck squamous cell carcinomas (HNSCC), and its overexpression is associated with increased recurrence. An underlying mechanism for eIF4E overexpression is gene amplification, and we wanted to determine whether eIF4E mRNA could serve as a prognostic maker of HNSCC. Methods: Tumor specimens from 26 HNSCC patients and oral tissues from 17 control subjects were examined for eIF4E and 4EBP1 by semiquantitative RT‐PCR and correlated with clinical and pathologic findings. Results: Unlike eIF4E mRNA alone, expression of eIF4E relative to 4EBP1 was a more precise predictor of HNSCC and its progression (P &lt; .01, Wilcoxon rank sum test). Eight of 26 patients (31%) had elevated eIF4E:4EBP1 (4E:4EBP1; &gt;25), and 7 of these (87.5%) had recurrence. Alternately, from 18 patients with low 4E:4EBP1 (&lt;25; 69%), only 5 patients had recurrence (30.1%). To determine the probability of no recurrence, Kaplan–Meier analysis showed significantly poor disease‐free survival in patients with elevated 4E:4EBP1 than those with low ratios (P &lt; .01, log rank test). Conclusions: Elevated 4E:4EBP1 significantly correlated with increased disease recurrence. Because 4EBP1 modulates eIF4E activity, our results highlight the importance of incorporating a joint analysis of eIF4E and 4EBP1 mRNAs in HNSCC patient care decisions.</description><subject>4EBP1</subject><subject>Adaptor Proteins, Signal Transducing - genetics</subject><subject>Adaptor Proteins, Signal Transducing - metabolism</subject><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>biomarker</subject><subject>Biomarkers, Tumor - metabolism</subject><subject>Biopsy, Needle</subject><subject>Carcinoma - genetics</subject><subject>Carcinoma - mortality</subject><subject>Carcinoma - pathology</subject><subject>Carcinoma, Squamous Cell</subject><subject>Chi-Square Distribution</subject><subject>Cohort Studies</subject><subject>Disease Progression</subject><subject>eIF4E</subject><subject>Eukaryotic Initiation Factor-4E - genetics</subject><subject>Eukaryotic Initiation Factor-4E - metabolism</subject><subject>Female</subject><subject>head and neck cancer</subject><subject>Head and Neck Neoplasms - genetics</subject><subject>Head and Neck Neoplasms - mortality</subject><subject>Head and Neck Neoplasms - pathology</subject><subject>Humans</subject><subject>Level 2b</subject><subject>Level of Evidence: Prognosis Study</subject><subject>Level of Evidence: Prognosis Study, Level 2b</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neoplasm Invasiveness - pathology</subject><subject>Neoplasm Recurrence, Local - genetics</subject><subject>Neoplasm Recurrence, Local - metabolism</subject><subject>Neoplasm Staging</subject><subject>Neoplasms, Squamous Cell - genetics</subject><subject>Neoplasms, Squamous Cell - mortality</subject><subject>Neoplasms, Squamous Cell - pathology</subject><subject>Otorhinolaryngology (head neck, general aspects and miscellaneous)</subject><subject>Otorhinolaryngology. Stomatology</subject><subject>Predictive Value of Tests</subject><subject>Prognosis</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>Risk Assessment</subject><subject>RNA, Messenger - analysis</subject><subject>RNA-Binding Proteins - genetics</subject><subject>RNA-Binding Proteins - metabolism</subject><subject>Sensitivity and Specificity</subject><subject>Squamous Cell Carcinoma of Head and Neck</subject><subject>Statistics, Nonparametric</subject><subject>Survival Analysis</subject><subject>Tissue Culture Techniques</subject><subject>Tumors</subject><issn>0023-852X</issn><issn>1531-4995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1Lw0AQhhdRtFYv_gDJRQQhdWc_kuyxllYrRUtR1NOyu5lgNElr1qL996Yf1pvsYWDnmXeYh5AToB2glF0Wpl50GAMhdkgLJIdQKCV3Satp8jCR7PmAHHr_RinEXNJ9csAgUYngvEVUtzLFwuc-mGYBDgeiH5gqDUT_agxBObnr-iCvglc06eq_QvceOFM5rI_IXmYKj8eb2iaPg_5D7yYc3V8Pe91R6LiKRKikshGTwqJVVqXAbOaEjSKMBEUAyoEl1jRPKmNQgUTa0BmzoFzMqeFtcr7OndXTjzn6T13m3mFRmAqnc68TJRKIQcqGvFiTrp56X2OmZ3VeNnI0UL00pZem9MpUA59uYue2xHSL_qppgLMNYLwzRVY3V-f-jxMRjSFZBsGa-8oLXPyzUo-6k5ff5eF6Jvef-L2dMfW7jmIeS_10d60nqjd4GN_2tOQ_5lOMBg</recordid><startdate>201110</startdate><enddate>201110</enddate><creator>Sunavala-Dossabhoy, Gulshan</creator><creator>Palaniyandi, Senthilnathan</creator><creator>Clark, Cheryl</creator><creator>Nathan, Cherie-Ann O.</creator><creator>Abreo, Fleurette W.</creator><creator>Caldito, Gloria</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley-Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201110</creationdate><title>Analysis of eIF4E and 4EBP1 mRNAs in head and neck cancer</title><author>Sunavala-Dossabhoy, Gulshan ; Palaniyandi, Senthilnathan ; Clark, Cheryl ; Nathan, Cherie-Ann O. ; Abreo, Fleurette W. ; Caldito, Gloria</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3964-959b6254beb9b9d12bfc4b66e640e1103128babab59aae915e0254f2b19c730a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>4EBP1</topic><topic>Adaptor Proteins, Signal Transducing - genetics</topic><topic>Adaptor Proteins, Signal Transducing - metabolism</topic><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>biomarker</topic><topic>Biomarkers, Tumor - metabolism</topic><topic>Biopsy, Needle</topic><topic>Carcinoma - genetics</topic><topic>Carcinoma - mortality</topic><topic>Carcinoma - pathology</topic><topic>Carcinoma, Squamous Cell</topic><topic>Chi-Square Distribution</topic><topic>Cohort Studies</topic><topic>Disease Progression</topic><topic>eIF4E</topic><topic>Eukaryotic Initiation Factor-4E - genetics</topic><topic>Eukaryotic Initiation Factor-4E - metabolism</topic><topic>Female</topic><topic>head and neck cancer</topic><topic>Head and Neck Neoplasms - genetics</topic><topic>Head and Neck Neoplasms - mortality</topic><topic>Head and Neck Neoplasms - pathology</topic><topic>Humans</topic><topic>Level 2b</topic><topic>Level of Evidence: Prognosis Study</topic><topic>Level of Evidence: Prognosis Study, Level 2b</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neoplasm Invasiveness - pathology</topic><topic>Neoplasm Recurrence, Local - genetics</topic><topic>Neoplasm Recurrence, Local - metabolism</topic><topic>Neoplasm Staging</topic><topic>Neoplasms, Squamous Cell - genetics</topic><topic>Neoplasms, Squamous Cell - mortality</topic><topic>Neoplasms, Squamous Cell - pathology</topic><topic>Otorhinolaryngology (head neck, general aspects and miscellaneous)</topic><topic>Otorhinolaryngology. Stomatology</topic><topic>Predictive Value of Tests</topic><topic>Prognosis</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>Risk Assessment</topic><topic>RNA, Messenger - analysis</topic><topic>RNA-Binding Proteins - genetics</topic><topic>RNA-Binding Proteins - metabolism</topic><topic>Sensitivity and Specificity</topic><topic>Squamous Cell Carcinoma of Head and Neck</topic><topic>Statistics, Nonparametric</topic><topic>Survival Analysis</topic><topic>Tissue Culture Techniques</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sunavala-Dossabhoy, Gulshan</creatorcontrib><creatorcontrib>Palaniyandi, Senthilnathan</creatorcontrib><creatorcontrib>Clark, Cheryl</creatorcontrib><creatorcontrib>Nathan, Cherie-Ann O.</creatorcontrib><creatorcontrib>Abreo, Fleurette W.</creatorcontrib><creatorcontrib>Caldito, Gloria</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Laryngoscope</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sunavala-Dossabhoy, Gulshan</au><au>Palaniyandi, Senthilnathan</au><au>Clark, Cheryl</au><au>Nathan, Cherie-Ann O.</au><au>Abreo, Fleurette W.</au><au>Caldito, Gloria</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Analysis of eIF4E and 4EBP1 mRNAs in head and neck cancer</atitle><jtitle>The Laryngoscope</jtitle><addtitle>The Laryngoscope</addtitle><date>2011-10</date><risdate>2011</risdate><volume>121</volume><issue>10</issue><spage>2136</spage><epage>2141</epage><pages>2136-2141</pages><issn>0023-852X</issn><eissn>1531-4995</eissn><coden>LARYA8</coden><abstract>Objectives/Hypothesis: The eukaryotic translation initiation factor 4E (eIF4E) in conjunction with its binding protein, 4EBP1, regulates the translation of cap‐dependent mRNAs. An aberrant increase in eIF4E shifts the balance in favor of translation of transcripts that promote cell proliferation and malignancy. eIF4E protein is commonly elevated in head and neck squamous cell carcinomas (HNSCC), and its overexpression is associated with increased recurrence. An underlying mechanism for eIF4E overexpression is gene amplification, and we wanted to determine whether eIF4E mRNA could serve as a prognostic maker of HNSCC. Methods: Tumor specimens from 26 HNSCC patients and oral tissues from 17 control subjects were examined for eIF4E and 4EBP1 by semiquantitative RT‐PCR and correlated with clinical and pathologic findings. Results: Unlike eIF4E mRNA alone, expression of eIF4E relative to 4EBP1 was a more precise predictor of HNSCC and its progression (P &lt; .01, Wilcoxon rank sum test). Eight of 26 patients (31%) had elevated eIF4E:4EBP1 (4E:4EBP1; &gt;25), and 7 of these (87.5%) had recurrence. Alternately, from 18 patients with low 4E:4EBP1 (&lt;25; 69%), only 5 patients had recurrence (30.1%). To determine the probability of no recurrence, Kaplan–Meier analysis showed significantly poor disease‐free survival in patients with elevated 4E:4EBP1 than those with low ratios (P &lt; .01, log rank test). Conclusions: Elevated 4E:4EBP1 significantly correlated with increased disease recurrence. Because 4EBP1 modulates eIF4E activity, our results highlight the importance of incorporating a joint analysis of eIF4E and 4EBP1 mRNAs in HNSCC patient care decisions.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>21898433</pmid><doi>10.1002/lary.22144</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0023-852X
ispartof The Laryngoscope, 2011-10, Vol.121 (10), p.2136-2141
issn 0023-852X
1531-4995
language eng
recordid cdi_proquest_miscellaneous_894817155
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects 4EBP1
Adaptor Proteins, Signal Transducing - genetics
Adaptor Proteins, Signal Transducing - metabolism
Adult
Aged
Biological and medical sciences
biomarker
Biomarkers, Tumor - metabolism
Biopsy, Needle
Carcinoma - genetics
Carcinoma - mortality
Carcinoma - pathology
Carcinoma, Squamous Cell
Chi-Square Distribution
Cohort Studies
Disease Progression
eIF4E
Eukaryotic Initiation Factor-4E - genetics
Eukaryotic Initiation Factor-4E - metabolism
Female
head and neck cancer
Head and Neck Neoplasms - genetics
Head and Neck Neoplasms - mortality
Head and Neck Neoplasms - pathology
Humans
Level 2b
Level of Evidence: Prognosis Study
Level of Evidence: Prognosis Study, Level 2b
Male
Medical sciences
Middle Aged
Neoplasm Invasiveness - pathology
Neoplasm Recurrence, Local - genetics
Neoplasm Recurrence, Local - metabolism
Neoplasm Staging
Neoplasms, Squamous Cell - genetics
Neoplasms, Squamous Cell - mortality
Neoplasms, Squamous Cell - pathology
Otorhinolaryngology (head neck, general aspects and miscellaneous)
Otorhinolaryngology. Stomatology
Predictive Value of Tests
Prognosis
Reverse Transcriptase Polymerase Chain Reaction
Risk Assessment
RNA, Messenger - analysis
RNA-Binding Proteins - genetics
RNA-Binding Proteins - metabolism
Sensitivity and Specificity
Squamous Cell Carcinoma of Head and Neck
Statistics, Nonparametric
Survival Analysis
Tissue Culture Techniques
Tumors
title Analysis of eIF4E and 4EBP1 mRNAs in head and neck cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T22%3A10%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Analysis%20of%20eIF4E%20and%204EBP1%20mRNAs%20in%20head%20and%20neck%20cancer&rft.jtitle=The%20Laryngoscope&rft.au=Sunavala-Dossabhoy,%20Gulshan&rft.date=2011-10&rft.volume=121&rft.issue=10&rft.spage=2136&rft.epage=2141&rft.pages=2136-2141&rft.issn=0023-852X&rft.eissn=1531-4995&rft.coden=LARYA8&rft_id=info:doi/10.1002/lary.22144&rft_dat=%3Cproquest_cross%3E894817155%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=894817155&rft_id=info:pmid/21898433&rfr_iscdi=true